Adcomm Member Survey Shows Continued Support For Virtual Meetings After Pandemic

Despite acknowledging that fully in-person meetings overall are better, survey respondents said they still want the flexibility that virtual attendance offers.

Virtual vote
Many advisory committee members said in a survey that virtual meeting options should remain after the coronavirus pandemic ends. • Source: Alamy

Many US Food and Drug Administration advisory committee members appear willing to sacrifice some discussion quality to ease the attendance burden for their meetings.

Data from a 3D Communications survey of advisory committee members who have participated in virtual meetings indicates that while the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from US FDA Performance Tracker

More from Regulatory Trackers